Prescribing practices and clinical predictors of glucose‐lowering therapy within the first year in people with newly diagnosed Type 2 diabetes

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-5491|32|12|1546-1554

ISSN： 0742-3071

Source： DIABETIC MEDICINE, Vol.32, Iss.12, 2015-12, pp. : 1546-1554

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Blood Glucose‐lowering Effect of T. procumbens L.: A Pilot Clinical Study in Individuals with Type 2 Diabetes

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 9, 2015-09 ,pp. : 1404-1411

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early glycaemic control among patients with type 2 diabetes and initial glucose‐lowering treatment: a 13‐year population‐based cohort study

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 8, 2015-08 ,pp. : 771-780

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and effectiveness of non‐insulin glucose‐lowering agents in the treatment of people with type 2 diabetes who observe Ramadan: a systematic review and meta‐analysis

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 7, 2015-07 ,pp. : 639-648

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rationale and design of a prospective clinical trial program to evaluate the glucose-lowering effects of colesevelam HCl in patients with type 2 diabetes mellitus

By Bays Harold E.   Cohen David E.  

Current Medical Research and Opinion, Vol. 23, Iss. 7, 2007-07 ,pp. : 1673-1684

Informa Healthcare

Access to resources Recommend Favorite

Glucose‐lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 554-559

John Wiley & Sons Inc

Access to resources Recommend Favorite